Mark N. Tompkins - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Lomond Therapeutics Holdings, Inc.

Filing Manager: Tompkins Mark N.
Reporting Manager: Mark N. Tompkins
Security: Lomond Therapeutics Holdings, Inc. Common Stock, par value $0.0001 per share
Shares outstanding: 29.7M shares
Disclosed Ownership: 1.19M shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 04:00 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Mark N. Tompkins	4%	1.19M	1.19M	0	/s/ Mark N. Tompkins	Mark N. Tompkins